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ABSTRACT The conformation of the 20-residue antibiotic ionophore alamethicin in macroscopically oriented phospholipid
bilayers has been studied using 15N solid-state nuclear magnetic resonance (NMR) spectroscopy in combination with
molecular modeling and molecular dynamics simulations. Differently 15N-labeled variants of alamethicin and an analog with
three of the -amino-isobutyric acid residues replaced by alanines have been investigated to establish experimental structural
constraints and determine the orientation of alamethicin in hydrated phospholipid (dimyristoylphosphatidylcholine) bilayers
and to investigate the potential for a major kink in the region of the central Pro14 residue. From the anisotropic 15N chemical
shifts and 1H–15N dipolar couplings determined for alamethicin with 15N-labeling on the Ala6, Val9, and Val15 residues and
incorporated into phospholipid bilayer with a peptide:lipid molar ratio of 1:8, we deduce that alamethicin has a largely linear
-helical structure spanning the membrane with the molecular axis tilted by 10–20° relative to the bilayer normal. In particular,
we find compatibility with a straight -helix tilted by 17° and a slightly kinked molecular dynamics structure tilted by 11°
relative to the bilayer normal. In contrast, the structural constraints derived by solid-state NMR appear not to be compatible
with any of several model structures crossing the membrane with vanishing tilt angle or the earlier reported x-ray diffraction
structure (Fox and Richards, Nature. 300:325–330, 1982). The solid-state NMR-compatible structures may support the
formation of a left-handed and parallel multimeric ion channel.
INTRODUCTION
To clarify the mechanisms by which voltage-gated ion
channels operate in biological membranes, considerable
effort has been devoted to investigation of the structure
and function of small peptide ion channels. Numerous
synthetic and naturally occurring peptides have been
examined using a variety of analytical methods. Among
the small natural polypeptides, the amphipathic 20-resi-
due peptaibophol alamethicin is probably the most ex-
tensively studied ionophore (Woolley and Wallace, 1993;
Sansom, 1993; Cafiso, 1994). The most common form of
alamethicin has the amino acid sequence (Pandey et al.,
1977) Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-
Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu-Gln-Phol, where the
N-terminal residue is acetylated and the C-terminal res-
idue is L-phenylalaninol. Because of its tractable size and
its significant voltage-dependent conductance in lipid
bilayer systems, alamethicin has been regarded an ideal
model for studying voltage-gated conformational
changes in -helical antibacterial peptides, transmem-
brane ion transport, and helix–membrane interactions for
membrane proteins in more general terms. Due to the
presence of a central proline residue within the poten-
tially membrane-buried part of the amino acid sequence,
alamethicin resembles a transmembrane domain in a typ-
ical transport/channel protein with several bilayer-span-
ning helices (Brandl and Deber, 1986).
The structure of alamethicin has been studied in the
crystalline phase using x-ray diffraction (XRD) (Fox and
Richards, 1982) and 13C–13C rotational resonance NMR
(Peersen et al., 1992), in organic solutions using 1H, 13C,
and 15N nuclear magnetic resonance (NMR) (Banerjee et
al., 1983; Esposito et al., 1987; Chandrasekhar et al., 1988;
Yee and O’Neil, 1992; Kelsh et al., 1992; Yee et al., 1997),
in amphiphilic (SDS micelles or POPC) environments using
1H NMR (Franklin et al., 1994; Brachais et al., 1998;
Jayasinghe et al., 1998), and investigated extensively using
molecular dynamics (MD) simulations (Biggin et al., 1997;
Gibbs et al., 1997; Breed et al., 1997; Sessions et al., 1998;
Tieleman et al., 1999a–c). Independent of the peptide en-
vironment (crystals, organic solution, or micelles), these
studies largely support the findings of Fox and Richards
(1982), namely that alamethicin exists predominantly in an
-helical conformation over its entire length. This structure
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conforms well with the high content of helix-stabilizing
-amino-isoburyric acid (Aib) residues. It is generally ac-
cepted that the structure contains a stable -helical confor-
mation in the N-terminal half of the sequence (residues 4–9
or 10), a less regular helix conformation in the C-terminal
half (residues 12–16), and greater conformational flexibility
for the residues outside these regions. The latter regions
most likely include a more extended structure in the outer
part of the C-terminal and potentially a bend near the Pro14
residue.
Despite a detailed picture of the overall structure of
alamethicin, its conformation and orientation when associ-
ated with lipid bilayers and the mechanism by which it
induces voltage-dependent ion conductance is still debated.
Models involving a long-lived open pore of aggregated
alamethicin helices in a transmembrane barrel-stave config-
uration (Baumann and Mueller, 1974) in the conductive
state are accepted in most of the studies cited above. More
discussion has concerned the conformation in the noncon-
ductive state. Models ranging from monomeric and multi-
meric rods on the lipid surface (Baumann and Mueller,
1974; Banerjee et al., 1985; Biggin et al., 1997; Tieleman et
al., 1999a; Kessel et al., 2000) via bent structures and
preaggregates with the C-terminal segment anchoring on the
lipid surface and the N-terminal segment extending into the
membrane (Fox and Richards, 1982; Franklin et al., 1994)
to purely transmembrane orientations (North et al. 1995;
Barranger-Mathys and Cafiso, 1996; Breed et al., 1997;
Jayasinghe et al., 1998; Tieleman, 1999b,c) have been pro-
posed. The various models have been supported by circular
dichroism (Wu et al., 1990; Huang and Wu, 1991; Wolley
and Wallace, 1993), neutron in-plane scattering (He et al.,
1996a,b), electron paramagnetic resonance (EPR) and NMR
on spin-labeled alamethicin (Barranger-Mathys and Cafiso,
1994, 1996; Jayasinghe et al., 1998), and 2H, 31P (Banerjee
et al., 1985), and 15N solid-state NMR (North et al., 1995)
experiments. These studies also demonstrated that the pep-
tide-to-lipid concentration, the temperature, and the hydra-
tion are important parameters for the peptide–lipid and
peptide–peptide interactions, and, thereby, for the configu-
ration of alamethicin in the membrane. Furthermore, it has
been investigated how the eight Aib residues, Pro14, and the
polar Gln7 residue are related to the structure, the channel
formation, and function for alamethicin (Brachais et al.,
1998; Sessions et al., 1998; Jaikaran et al., 1997; Dathe et
al., 1998; Tieleman et al., 1999b).
Among the methods listed above, solid-state NMR of
isotope-labeled peptides incorporated into macroscopically
oriented phospholipid bilayers is particularly useful for ob-
taining detailed information about the structure, dynamics,
and orientation of membrane-associated peptides and pro-
teins at the atomic level (Bechinger et al., 1991, 1993;
Ketchem et al., 1993; Ramamoorthy et al., 1995; Opella et
al., 1999; Kovacs et al., 2000). Using this approach, North
et al. (1995) demonstrated that the N-terminal part of ala-
methicin is oriented with the helix axis parallel to the
bilayer normal. By arguments concerning motional averag-
ing, this result was extended to suggest a straight transmem-
brane configuration of the entire peptide. Considering the
large number of models suggesting a kink around the Pro14
residue and a flexible C-terminal of alamethicin potentially
at the membrane surface in the nonconducting state, it is
relevant also to consider the central and C-terminal parts of
the peptide. Thus, in this study, the helix orientation(s)
relative to the bilayer normal, including the potential for a
proline-induced kink of the helix structure, are investigated
in more detail using 15N solid-state NMR on three alam-
ethicin peptides differently labeled with 15N at the Ala6,
Val9, and Val15 residues. Furthermore, to investigate the
role of the Aib residues a similar analysis is performed for
an alamethicin analogue Ac-Ala-Pro-Aib-Ala-Aib-Ala-Gln-
Aib-Val-Aib-Gly-Leu-Ala-Pro-Val-Ala-Aib-Glu-Gln-Phol,
where three of the Aib residues (underlined) have been
replaced by Ala. Finally, the structural constraints estab-
lished using solid-state NMR for the various labeled alam-
ethicins are analyzed in relation to the earlier XRD structure
(Fox and Richards, 1982) and a series of model structures
obtained in this work by modeling and molecular dynamics
calculations. The results are discussed in light of previous
models for alamethicin in monomeric forms as well as part
of a multimeric ion channel.
MATERIALS AND METHODS
Sample preparation
Alamethicin 15N-labeled on Ala6, Val9, and Val15 (three different peptides)
was purchased from Quality Controlled Biochemicals, Inc. (Hopkinson,
MA). The alamethicin analog with three of the Aib positions replaced by
alanine (sequence given above) was prepared by solid-phase peptide syn-
thesis (t-Boc chemistry) with 15N-labeled amino acids at the Ala6 and Ala16
positions (two different peptides). The purity and quality of all peptides
were tested by high pressure liquid chromatography and mass spectros-
copy. 15N-labeled t-BOC alanine was purchased from Cambridge Isotope
Laboratories (Andover, MA). Dimyristoylphosphatidylcholine (DMPC)
was obtained from Avanti Polar Lipids (Alabaster, AL). Both peptides and
phospholipids were used without further purification.
The three differently 15N-labeled alamethicin samples were prepared by
co-dissolving 10 mg of the peptide (5.2 mole) in 70 l methanol (95%,
spectroscopic grade) with 60 mg DMPC in 70 l methanol corresponding
to a peptide:lipid molar ratio of 1:8. For the alamethicin analogues we used
the same proportionality but with a lower amount of peptide (5.5 mg). For
each sample, the solution was distributed equally on 12 glass plates of
dimension 10  10  0.1 mm3 cut from standard microscope coverslips
(Menzel-Gla¨ser, Germany) and rinsed carefully in methanol before use.
The solvent was removed by first air drying overnight at ambient temper-
ature and pressure and then evaporating 8 h under high vacuum. The
samples were hydrated above de-ionized water in a closed dessicator
(100% humidity) in 3 days at 23°C followed by 2 days at 43°C. The
hydrated peptide/lipid mixtures were aligned into parallel multilayers by
compressing the 12 glass plates in a stack. The stack was immediately
placed in an airtight sample chamber made of Macor (Corning Glass
Works, Corning, WY) equipped with a water reservoir to maintain the
hydration constant throughout several days of NMR experiments with
intense rf pulsing as described earlier (Nielsen et al., 1995).
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Flat-coil NMR
15N solid-state NMR experiments were performed at 30.40 and 40.52 MHz
using Varian XL-300 (7.05 T) and Varian Unity-INOVA 400 (9.39 T)
NMR spectrometers, respectively, equipped with home-built 15N/1H dou-
ble-tuned flat-coil NMR probes (Nielsen et al., 1995). An rf field strength
of 35 kHz was used for 1H and 15N during cross-polarization (CP) (Pines
et al., 1973), whereas an rf field strength was 56 kHz for 1H pulses and
decoupling. All experiments used 2.5–3.5-s relaxation delay, 0.4–2.5-ms
Hartman–Hahn contact period for CP, and a 20-ms acquisition period with
1H decoupling. The rf coil (rectangular 4-turn flattened rf coil; inner
dimension 8  14  4 mm3) and the sample chamber were oriented such
that the bilayer normal was parallel to the static magnetic field (B0). To
avoid long-term deterioration (dehydration) of the sample induced by
temperature gradients in the sample chamber during rf irradiation, the part
of the chamber containing the sample was “cooled” by an air stream at
23°C, while the part with the water reservoir was “heated” by an air stream
at 36°C (Nielsen et al., 1995). 15N chemical shifts were determined using
a standard CP experiment, whereas 1H–15N dipolar couplings were mea-
sured using a 2D separated local field (SLF) (Hester et al., 1975) experi-
ment with BLEW-12 (Burum et al., 1981) homonuclear multiple-pulse
decoupling in the t1 period. We note that this experiment was chosen
instead of the resolution-wise very attractive PISEMA experiment (Wu et
al., 1994) because of the limited rf capabilities of our flat-coil NMR probe,
which did not allow for well-resolved PISEMA spectra without folding
ambiquities. All experiments were optimized using a single crystal of a
doubly 15N-labeled N-acetyl-L-valyl-L-leucine (Ac-Val-Leu) dipeptide.
Prior to the 15N experiments, the orientation of the DMPC bilayers in the
hydrated peptide/lipid samples was checked using a standard 31P single-
pulse experiment at 7.05 T (121.4 MHz) providing information about the
orientation of the 31P chemical shift tensors for the phosphate headgroups
in the phospholipids. The 15N chemical shifts were referenced relative to an
external saturated solution of 15NH4NO3 (we note that the isotropic chem-
ical shift of 15NH4NO3 is 22.3 ppm relative to liquid 15NH3).
Restriction plots
The orientation of a 15N-labeled peptide plane relative to B0, which
coincides with the normal of the lipid bilayer, may be determined by
measuring the orientation of the amide 15N chemical shift and 1H–15N
dipolar coupling tensors relative to B0 and use empirical relations for the
orientation of these tensors relative to the peptide plane (Opella et al.,
1987; Bechinger et al., 1991; Wu et al., 1995). For this purpose, it is
convenient to express the observed chemical shift (obs, in ppm) and
dipolar coupling (bobs, in angular frequency) as
obs iso aniso 
m2
2 
m2
2
R2,mCS PDm,m2 	PECS
dm,02 ELexp
imEL, (1)
bobs bNH 
m2
2
D0,m(2) 	PENHdm,02 ELexp
imEL, (2)
where iso  (xx  yy  zz)/3, aniso  zz  iso, (R2,0CS)P  1,
(R2,1CS )P  0, (R2,2CS )P  CS/6, CS  (yy  xx)/aniso, and bNH 
	I	S0/(4
rNH3 ). ii denotes the principal elements for the chemical
shift tensor (zz  iso  xx  iso  yy  iso), bNH/2
 the dipolar
coupling constant, and rNH the internuclear distance. P is the principal axis
frame, E the peptide plane frame with xE along N–H and zE being the
normal to the plane (Fig. 1 A), and L the laboratory-fixed frame. The
coordinate systems are related by the Euler angles 	PE  {PE, PE, 	PE}
and 	EL  {EL, EL, 0} (Fig. 1 B). D(2)(	) and d(2)() are second-rank
Wigner and reduced Wigner matrices, respectively.
Using Eqs. 1–2 along with empirical values for the magnitudes (xxN , yyN ,
zz
N , bNH/2
) and orientations (	PECS,N, 	PENH) of the 15N chemical shift and
1H–15N dipolar coupling tensors, the measured obs and bobs values may be
interpreted in terms of the orientation of the peptide plane relative to the
lipid bilayer. The possible solutions (considering uncertainties for the
empirical and experimental parameters) are conveniently visualized by
restriction plots showing the pairs of angles EL and EL compatible with
the experimental values (Bechinger et al., 1991; Ramamoorthy et al.,
1995). The magnitude and orientation of the 15N chemical shift tensors
relative to the peptide plane have been determined for several peptides
(e.g., Harbison et al., 1984; Oas et al., 1987; Hartzell et al., 1987; Teng and
Cross, 1989; Bechinger et al., 1991; Mai et al., 1993; Shoji et al., 1993;
North et al., 1995; Ramamoorthy et al., 1995; Wu et al., 1995; Kovacs and
Cross, 1997) and found to display relatively small variations. In this work,
we assume that the 15N chemical shift tensor is not subject to significant
motional averaging beyond that induced by the fast motion about the
bilayer normal as typically encountered in hydrated lipid samples. Thus,
we assume the tensor characterized by the typical values of xxN  30  5
ppm, yyN  53  5 ppm, zzN  195  5 ppm, and 	PECS,N  {90°, 90°,
17  4°}, where the uncertainties accomodate residue and secondary
structure-specific variations in the parameters. The tensor is oriented such
that the yy axis (yPN) is perpendicular to the peptide plane and the axis of
the unique (least shielded) element zz (zPN) being tilted 17 4° away from
the N–H bond within the peptide plane as visualized by the ORTEP-type
(Burnett and Johnson, 1996) plot in Fig. 1 A. We note that yPN in some
studies (Wu et al., 1995) has been reported tilting away from the peptide
plane normal by 10–30° (corresponding to PECS,N  80° to 60°). This
tilt only affects the restrictions marginally and has accordingly been
disregarded in this study. The 1H–15N dipolar coupling tensor is axially
FIGURE 1 ORTEP-type representation. (A) The orientation of the 15N
chemical shift tensor, the 1H–15N dipolar coupling tensor (oriented along
the N–H bond), and an ideal helix axis relative to the peptide plane (the
principal elements and the Euler angles are given in the text) and the static
magnetic field (B0). (B) The Euler angles relating any of the principal axis
frames (P) via the molecular frame (E) to the laboratory frame (L).
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symmetric, aligned along the N–H internuclear axis (i.e., 	PENH  {0°,
90°, 0°}), and characterized by the dipolar coupling constant bNH/2
 
9.9 0.2 kHz (corresponding to an internuclear distance of rNH 1.07 Å)
(Wu et al., 1995). For an ideal -helix structure (specifically calculated
using     57°) the orientation of the helix axis relative to the
peptide-plane frame may, to a good approximation, be described by the
Euler angles 	EH  {13°, 91°, 0°} as illustrated in Fig. 1 A. The angle
between the helix axis and B0 is denoted , and  denotes the rotational
pitch around the helix axis. Based on these definitions, it is possible to
establish restrictions between the helix tilt-angle  and the pairs of angles
EL and EL and thereby determine the tilt angle for a potential local
-helix axis relative to the normal of the bilayer.
All numerical simulations, generation of restriction plots, and iterative
fitting to XRD, modeled, and molecular dynamics structures were accom-
plished on a 450-MHz Pentium-III workstation operating under Linux 6.1
using the SIMPSON solid-state NMR simulation package (Bak et al.,
2000). Simulation and generation of restriction plots at 0.5° resolution for
three peptide planes required 21 s of CPU time, whereas iterative fitting to
model structures typically required a processing time of 1 min.
Molecular dynamics calculations and
molecular modeling
MD calculations were performed in a simulated solvent designed to emu-
late the lipid bilayer environment (chloroform, dielectric constant 4.806 at
20 K, comparing reasonably with the dielectric constant of about 2–4 for
the hydrocarbon region in lipid bilayers). The calculations were carried out
on an SGI octane (IRIX64 6.5) workstation using the MMFF94S (planar
sp2 N) force field implemented in the Macromodel (Mohamadi et al.,
1990) modeling program. The simulations typically required 234 s of CPU
time per nanosecond of simulation time. Each run had a starting temper-
ature of 1000 K, running temperature of 300 K with a 0.2-ps coupling to
a thermal bath, and a final temperature of 0 K. The total run time was 100
ps with a time step of 1.5 fs. Simple peptide backbone models involving
various combinations of -helix and 310-helix structure elements were
generated using the WHAT IF program (Vriend, 1990) on a 450-MHz
Pentium III workstation under Linux 6.1.
RESULTS
Solid-state NMR restrictions
Figure 2 shows 15N CP and 2D 1H–15N SLF spectra for the
three singly 15N-Ala6-, 15N-Val9-, and 15N-Val15-labeled
alamethicin peptides incorporated with a peptide:lipid ratio
of 1:8 into hydrated DMPC phospholipid bilayers and ori-
ented with the membrane normal parallel to the magnetic
field. We note that this peptide:lipid ratio is relatively high
and in the regime where all molecules is expected to be
inserted into the membrane as deduced by oriented circular
dichroism (He et al., 1996b). Evidently, all NMR spectra
contain a single narrow 15N resonance in the obs  160–
180-ppm region with a line width at half height of 8–16
ppm. The actual values for the chemical shifts and dipolar
couplings determined from the various experimental spectra
are listed in Table 1. The relatively narrow 15N resonances
indicate that the peptides are, within a small margin, aligned
uniformly with respect to the bilayer normal. This finding is
supported by 31P spectra (not shown), which, for the same
samples, contain a single relatively narrow (line width 2–4
ppm) resonance at 28 ppm (relative to external 85% H3PO4)
for the phosphate headgroups. This indicates a relatively
small orientational distribution (i.e., mosaic spread) for the
planar phospholipid bilayers. Furthermore, the 15N chemi-
cal shifts are close to the low-field shoulder of the typical
15N powder pattern for peptides in hydrated lipid mem-
branes (in the present case corresponding to zzN  195  5
ppm). We note that the 15N CP spectra (in particular for
Ala6 and Val15) give indication of a weak powder pattern
with the most intense singularity around 50–55 ppm being
compatible with the typical chemical shift values given
above. From the measured chemical shifts, it can immedi-
ately be deduced that the amide 15N chemical shift tensors
FIGURE 2 15N CP (left column) and 1H–15N 2D SLF (right column)
spectra obtained at 9.39 T of (A) 15N-Ala6-, (B) 15N-Val9-, and (C)
15N-Val15-labeled alamethicin incorporated into hydrated DMPC bilayers
(peptide:lipid ratio of 1:8) and oriented between glass plates arranged with
the plane perpendicular to the B0 direction. The spectra were recorded
using 3.5-s relaxation delay, 2.5-ms Hartmann–Hahn contact time,
20,000–25,000 scans for the CP experiments, and 2700 scans for each of
the 16 t1 increments (t1  57.6 s) in the SLF experiments.
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for Ala6, Val9, and Val15 all have zPN (corresponding to zzN )
and thereby the N–H internuclear axis (cf. Fig. 1 A) aligned
approximately parallel to B0, i.e., EL 90°. Assuming that
alamethicin (as in methanol and micelle environments)
largely adopts an -helical secondary structure where the
helix axis within 10–15° (see below) is parallel to the N–H
axis, this information suggests that the peptide over its
entire length is configured in a transmembrane orientation
relative to the planar DMPC bilayers. This first conclusion
is supported by the 1H–15N dipolar splittings (bobs/2
),
which impose complementary restrictions to the orientation
of the peptide planes relative to B0, because the N–H dipolar
coupling tensor is oriented differently than the 15N chemical
shift tensor relative to the peptide plane (see Fig. 1 A). By
direct comparison of the orientation-dependent dipolar cou-
plings (bobs/2
) of 8.9, 7.8, and 8.4 kHz (compensated for
scaling by BLEW-12 irradiation) measured for the Ala6,
Val9, and Val15 15N-labeled alamethicins, respectively, with
the nonscaled dipolar coupling of bNH/2
  9.9 kHz, the
angle between the N–H bond vector and the B0 direction
may be estimated to be in the order of 14–18°.
To exploit more rigorously the structural constraints from
the obs and bobs/2
 values and thereby obtain a more
detailed picture of the conformation of alamethicin in phos-
pholipid bilayers, it is useful to use these values along with
the empirically established tensor versus peptide plane in-
formation (cf. Fig. 1 A) to generate restriction plots for the
allowed EL and EL Euler angles. Restriction plots corre-
sponding to obs and bobs/2
 individually and in combina-
tion (the intersection of the two plots) determined for the
Ala6, Val9, and Val15 peptide planes in the three differently
15N-labeled alamethicin samples are shown in Fig. 3. In
these plots, the black areas represent pairs of EL and EL
angles that are compatible with the experimental data within
the limits of the estimated uncertainties on the experimental
and empirically established tensor parameters. From the
intersection plots it is seen that all three peptide planes are
compatible with EL values in the vicinity of 90° with an
EL-dependent variation of18°,23°, and21° for Ala6,
Val9, and Val15, respectively. EL displays variations in the
angular regions 170–193° (Ala6), 181–204° (Val9), and
164–186° (Val15) depending on EL.
Within the assumption that the peptide planes individu-
ally are parts of ideal (and possibly only local) -helical
structures, the allowed pairs of EL and EL angles may be
rationalized by comparison with restrictions corresponding
to different helix tilt angles  calculated using 	EH  {13°,
91°, 0°} and included as grey contours in the intersection
plots of Fig. 3. This representation reveals that the experi-
mental EL, EL restrictions are compatible with tilted -he-
lices characterized by  angles in the order of 10–23°,
11–23°, and 21–29° for the Ala6, Val9, and Val15 peptide
planes, respectively. As an interesting result, it appears that
none of the restrictions are compatible with a pure -helix
crossing the membrane with the helix axis parallel to the
bilayer normal (i.e.,   0°). It is also evident that the two
labeled N-terminal residues are compatible with slightly
smaller helix tilt angles than the labeled C-terminal residue.
We note that this observation is even more pronounced if
we compare the experimental restrictions with those from a
regular 310 helix (calculated using 	EH  {25°, 100°, 0°}
corresponding to a helix with   50° and   20° for
all residues), which, for comparison, is included in the
dipolar coupling restriction plot for the Val15 residue in Fig.
3 C. This plot indicates compatibility between the experi-
mental restrictions for Val15 with a local 310 helix tilting by
as much as   25–45° relative to the bilayer normal.
Finally, it is interesting to note that the restrictions for the
three residues taken individually (i.e., not coupled in a
structure, see below) all would intuitively be compatible
with a straight -helix tilting 21–23° relative to the bilayer
normal. The impact of the average angles of 16° (Ala6), 17°
(Val9), and 25° (Val15) on the orientation of the individual
peptide planes relative to the bilayer normal is visualized
TABLE 1 15N Chemical shifts (obs) and
1H–15N dipolar couplings (bobs/2) along with the associated restrictions (cf. Fig. 3) on
EL, EL, and  obtained by solid-state NMR for alamethicin
15N-labeled at the Ala6, Val9, and Val15 residues and an alamethicin
analog (see text) 15N-labeled at the Ala6 and Ala16 positions
Peptide
15N
label
obs*
(ppm)
bobs/2
†
(kHz)
EL
‡,§
(°)
EL
§
(°)
§,¶
(°)
Alamethicin Ala6 176  5 8.9  0.3 170–193 72–108 10–23
Val9 181  5 7.8  0.3 181–204 67–113 11–23
Val15 160  5 8.4  0.3 164–186 69–111 21–29
Alamethicin Ala6 174  5 — 159–227 56–123 18–33
analog Ala16 154  5 — 159–232 54–126 21–40
All peptides were incorporated into planar DMPC bilayers with a peptide:lipid ratio of 1:8.
*Relative to 15NH4NO3 (saturated aq. solution).
†Corrected for a scaling of 0.475 by BLEW-12 (Burum et al., 1981).
‡EL  180° also applies.
§Calculated under the assumption of xxN  30  5 ppm, yyN  53  5 ppm, zzN  195  5 ppm, 	PECS,N  {90°, 90°, 17  4°}, bNH/2
  9.9 
0.2 kHz, and 	PENH  {0°, 90°, 0°}.
¶Obtained from the intersection between the experimental EL, EL restrictions and the theoretical restrictions representing local -helix structures ( 
  57°) oriented relative to the peptide plane as 	EH  {13°, 91°, 0°} and with the helix axis inclined by the angle  to the bilayer normal.
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graphically in the right-hand side of Fig. 3. All orientational
restrictions for the different peptide planes are summarized
in Table 1.
To examine the influence of the helix-stabilizing Aib
residues on the conformation of alamethicin in phospholipid
bilayers, we measured the 15N chemical shifts for a simi-
larly prepared sample of an analog of alamethicin Ac-Ala-
Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Ala-Pro-
Val-Ala-Aib-Glu-Gln-Phol differing from alamethicin in
the exchange of the Aib residues 1, 13, and 16 by alanine.
Figure 4 shows 15N CP spectra for two different versions of
this peptide 15N-labeled at the Ala6 and Ala16 positions and
incorporated into an oriented DMPC bilayer using the pro-
cedure described above. In full consistency with the spectra
for alamethicin, these samples yield a single 15N resonance
(20–30-ppm line width) in the low-field region of the typ-
ical 15N amide powder spectrum. The specific obs values of
174 and 154 ppm determined for the Ala6 and Ala16 sam-
ples, respectively, lead to the {EL, EL} and  restrictions
represented graphically in the right-hand side of Fig. 4.
Clearly, the 15N chemical shifts and, accordingly, the solid-
state NMR orientational restrictions are very similar to those
observed for the original peptide and thereby compatible to a
peptide with local -helical secondary structures tilting by
5–25° and 15–35° relative to the bilayer normal in vicinity of
the Ala6 and Ala16 residues, respectively. Comparing the re-
sults obtained for alamethicin and its analog, it is interesting to
note that, consistently, the chemical shifts observed in the
C-terminal end are slightly smaller than those observed for the
central and N-terminal part of the peptide. This may potentially
be ascribed to a less regular helical structure in this part of the
peptide. Finally, it should be noted that the similarity between
the conformation of alamethicin and its Aib-deficient analog
agrees well with the findings of Cafiso and coworkers (Bar-
ranger-Mathys and Cafiso, 1996; Jayasinghe et al., 1998) using
EPR on various spin-labeled derivatives of alamethicin.
FIGURE 3 Restriction plots (left three columns) and orientation of peptide planes and helix axes relative to the laboratory frame (right column, zLB0)
for (A) 15N-Ala6, (B) 15N-Val9, and (C) 15N-Val15 alamethicin corresponding to the parameters in Table 1. The restriction plots for the chemical shift (first
column), dipolar coupling (second column), and their intersection (third column) takes into account uncertainties of 5 ppm and 0.3 kHz for the
experimental obs and bobs/2
 values, respectively, as shown in Table 1 and visualized by ORTEP-type plots in the fourth column of this figure. The
intersection plots include shaded restrictions corresponding to ideal local  helices with different tilt angles  relative to the bilayer normal. For comparison,
the dipolar coupling restriction plot in (C) also includes similar contours for an ideal 310 helix (see text).
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Structure models
With the experimental data interpreted in terms of the
orientation of the individual peptide planes relative to the
membrane normal, it is relevant to examine in more detail
potential consequences of the combination of these local
structure constraints on the overall structure of alamethicin
in phospholipid bilayers. For this purpose, we analyze the
compatibility of the solid-state NMR data with the XRD
structure of crystalline alamethicin, a series of simple back-
bone structures involving different combinations of - and
310-helix secondary structure elements, and structures ob-
tained by molecular dynamics calculations. The backbone
structures for a representative set of the proposed models
are visualized in a 3D Geomview representation (Levy et
al., 1996) in Fig. 5 with specification of the three labeled
peptide planes and average molecular axes for the N- and
C-terminal ends of the molecule (see below). Figure 6 gives
a graphical representation of the  and  backbone torsion
angles for the same set of structures.
The coordinates for the XRD structure (Fox and Rich-
ards, 1982) in Fig. 5 A were obtained from the Protein Data
Bank (http://www.rcsb.org/pdb/; PDB ID: 1amt). A series
of ideal 20-residue peptide backbone structures were gen-
erated to model fully -helical (    57°, Fig. 5 B),
fully 310-helical (  50°,   20°, Fig. 5 C), and
various mixtures of such - and 310-helices with the n
N-terminal residues being -helical and the 20  n C-
terminal residues being composed of 310-helix elements
FIGURE 4 15N CP NMR spectra (left column) and restriction plots (right
column) determined for the alamethicin analog Ac-Ala-Pro-Aib-Ala-Aib-
Ala-Gln-Aib-Val-Aib-Gly-Leu-Ala-Pro-Val-Ala-Aib-Glu-Gln-Phol with
15N-labeling at the (A) Ala6 and (B) Ala16 residue. The experimental
spectra were recorded at 7.05 T using CP with 1000-s contact time, 3-s
relaxation delay, and (A) 130,000 and (B) 110,000 scans. Val9
Val15
Val15
Val15
Val9
Ala6Ala
6
Ala6
Val9
Val9
Val15
Val15
Val15
Val9
Ala6Ala6Ala
6
Val9
D E F
BC
N
A C
FIGURE 5 Representative backbone structures for various alamethicin
models. (A) The XRD-structure determined by Fox and Richards (1982).
(B) An ideal -helix (    57°). (C) An ideal 310 helix (  50°,
  20°). (D) A 100-ps wild-type MD structure. (E) A 100-ps Pro14 to
Ala14 mutant MD structure. (F) A 100-ps MD structure initialized with
forced 310 structure for the C-terminal (see text). For all structures, the
orientation of the peptide (specified by the  and  angles in Table 2) have
been optimized for optimum agreement with the EL and EL structure
contraints determined by solid-state NMR. The vertical axis and the black
arrows at the 15N position of each labeled peptide plane represents the
orientation of the B0 field. The plane of the paper corresponds to  0. The
black dots represents C carbons of the hydrophilic Aib3, Gln7, Aib10,
Pro14, and Glu18 residues.
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using n values of 12–14. The latter crude models have been
inspired by the structures determined by XRD, solution
NMR, and molecular dynamics calculations, which all, in
some respect, support models with extended structures in
the C-terminal of alamethicin. Finally, to investigate the
propensity of alamethicin to change its conformation, a
series of molecular dynamics calculations were performed
using chloroform as a model solvent, which, with respect to
dielectric constant, closely resembles the present lipid bi-
layer environment. Three series of calculations were con-
ducted including wild type alamethicin, a mutant with Pro14
exchanged with Ala, and alamethicin with the C-terminal
portion initially forced into a 310 geometry. All variants
largely retain (or re-acquire, in the case of the 310 geometry)
an -helical structure after 100 ps as judged using the DSSP
program (Kabsch and Sander, 1983) although the  and 
profiles for the various structures display some variation
(Fig. 6), especially in the regions around the C-terminal
phenylalaninol and the central Gly11-X-X-Pro14 motif. We
note that the  and  angles over the first 16–17 residues
for all structures are quite close to the average values of 
62° and   41° determined in a survey over helices in
a large number of protein crystal structures (Barlow and
Thornton, 1988).
For the wild-type MD calculation, the structure (Fig. 5 D)
remains essentially unchanged after 100 ps, except that the
C-terminal phenylalaninol residue becomes slightly un-
wound relative to the starting structures (all the structures
showed similar behavior in this respect). It has been shown
in both model peptide studies (von Heijne, 1991; Balles-
teros and Weinstein, 1992; Deber et al., 1990; Piela et al.,
1987; Nilsson et al., 1998; Jacob et al., 1999) and from
crystal structures of membrane proteins (Bywater et al.,
2001) that proline residues sometimes have a tendency to
cause a distortion in the helix. This is due to the lack of a
hydrogen bond between the imido N atom of the proline and
the carbonyl oxygen of the (i 3)th preceding residue. This
is commonly referred to as a “kink.” Although this is by no
means universal, when such a kink occurs, one observes that
the  angles of the (i  3)th residue is in the range 115°
to 135° and that of the (i  4)th residue is 100°
(Bywater et al., 2001). Often there is an out-of-plane dis-
tortion of the (i 1)th peptide bond by up to20°. In the
wild-type peptide, the value of the  angle of the (i  3)th
residue (Gly11) does depart somewhat from the standard
-helix values, but the (i  2)th residue (Leu12) is, if
anything, more distorted, with not only slightly deviant 
and  angles but a distinctly nonplanar peptide bond (10°
out of plane). The distance between the Pro14 imido N and
the carbonyl O of the (i  3)th residue is 4.4 Å. This would
normally be 2.8 Å if a hydrogen bond had been possible at
this site. Nevertheless, the DSSP program regards the entire
peptide as being -helical.
For the Pro14 to Ala14 mutant (Fig. 5 E), no major
changes were observed during the simulations. The slight
kinking referred to for the wild type appears here too, but
much less pronounced. This time the (i  1)th peptide bond
is almost planar but the (i  2)th peptide bond is about 7°
out of plane. The hydrogen bond distance between the Ala14
amide N and Leu11 carbonyl O is 3.3 Å, which is at the outer
limit of what can be classified as a hydrogen bond. Like-
wise, the 310-forced structure (Fig. 5 F) reverts to an -he-
lix, with the exceptions that the Pro14 and Leu12 residues
develop somewhat deviant , , and  torsion angles. To
judge from the starting structure, this is more a memory
from the structure prior to the enforced change in geometry
to the 310-helix conformation in the C-terminal region,
rather than a memory from the forced conformation. This
suggests that the departures from true -helix geometry do
derive from the presence of a proline. It should be reiterated
that these deviations in the torsion angles are not sufficient
for a secondary structure-determination program like DSSP
to consider that the helix is kinked, and to the extent that
they are departures from classical -helix geometry, they
are very different from those commonly claimed (e.g., By-
water et al., 2001) as being the kink introduced by proline.
Overall, these observations agree favorably with the con-
clusions of previous MD simulations in solution and in lipid
bilayers (Breed et al., 1997; Tieleman et al., 1999b,c).
FIGURE 6 (A)  and (B)  torsion angles for the six structures shown in
Fig. 5, including the XRD structure (dotted line), an ideal -helix (solid
line), an ideal 310 helix (dashed line), and wild-type (dot-dashed line),
Pro14 to Ala14 mutant (dot-dot-dashed line), and 310-forced (dot-dot-dot-
dashed line) MD calculations.
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Compatibility between solid-state NMR
restrictions and structure models
The compatibility between the various backbone structures
and the orientational constraints for the three 15N-labeled
peptide planes obtained by solid-state NMR may be evalu-
ated numerically by varying the overall orientation of the
peptide relative to the B0 direction (i.e., the bilayer normal).
Different orientations will lead to different chemical shift
and dipolar coupling parameters and thereby orientational
restrictions on the EL and EL angles, which may be
compared to the experimentally established restrictions. The
overall orientation of the peptide may be described by a tilt
angle  of the average helix axis with respect to the mem-
brane normal and a rotational pitch angle  around the helix
axis (Fig. 1 A). Using this notation, the root-mean-square
deviation (RMSD) between the actual - and -dependent
EL and EL angles and the closest pair of angles within the
experimental restrictions (summed over the three peptide
planes) may be minimized using Levenberg–Marquardt
nonlinear regression (Bard, 1974) to define the optimum
orientation of the peptide relative to the bilayer normal.
Because the RMSD function typically is only partially con-
tinuous in this case (in particular for large  values) and may
have several local minima, this procedure was supple-
mented by a grid search over the two variables to ensure
determination of a global minimum on the RMSD surface.
We note that the rotational pitch, in general, may vary over
the full 0–360° range, with its reference point fixed to a
well-defined molecular axis (defined in Table 2), while the
tilt angle typically will be searched in the area of 0–45°,
corresponding to the tilt angles reported for transmembrane
helices so far (e.g., Bowie, 1997; Kukol et al., 1999; Ma-
rassi et al., 1999).
Typical RMSD curves are shown in Fig. 7, which, for the
purpose of further discussion, reflect optimization of the
orientations for the XRD structure, the straight -helix, and
the 100-ps wild-type MD structures represented in Fig. 5, A,
B, and D, respectively. Clearly, in all three cases, the
optimization leads to a well-defined minimum at   12°
and   26° for the XRD structure,   17° and   341°
for the ideal -helix, and   11°, and   232° for the
wild-type MD structure. Furthermore, from the minimum
RMSD values, it appears that the two theoretical model
structures (RMSD 4.2–5.1) are in somewhat better agree-
ment with the solid-state NMR restrictions than is the XRD
structure (RMSD  13.6). It should also be noticed that the
solid-state NMR restrictions appear not to support peptides
crossing the membrane with the molecular axis parallel to
the bilayer normal. For example, the RMSD value for the
ideal -helix with   0° is 22, being a direct measure for
the considerable angular distance between the experimental
restrictions and central grey helix-tilt contour (dot) in the
restriction plot in the third column of Fig. 3. With the
structures tilted away from the B0 direction, we also observe
a characteristic dependency on the rotational pitch angle ,
which will be addressed later with specific attention to the
XRD and wild-type MD structures. The optimum tilted
conformations for various models are visualized graphically
in Fig. 5, where the bilayer normal is vertical as indicated by
the black arrows located at each of the labeled peptide
TABLE 2 Compatibility between the solid-state NMR restrictions and various backbone model structures for alamethicin
Structure RMSD*
†
(°)
‡
(°)
N
§
(°)
C
§
(°)
Backbone¶
length/height
(Å)
Hydrophic
length/height
(Å)
XRD** 13.6 12 26 5 28 30.0/28.5 22.0/21.7
-helix†† 4.2 17 341 – – 24.7/23.4 18.5/17.1
310-helix†† 5.7 21 244 – – 38.6/36.1 28.3/26.1
1-12: -helix, 13-20: 310-helix†† 12.1 12 250 15 17 30.3/29.5 20.3/19.5
1-13: -helix, 14-20: 310-helix†† 30.0 12 255 19 3 29.7/29.3 20.0/19.1
1-14: -helix, 15-20: 310-helix†† 16.4 8 188 12 12 29.1/29.0 19.7/19.4
Wild-type MD 5.1 11 232 20 3 26.5/25.8 20.8/20.2
Pro14 to Ala14 mutant MD 9.5 8 234 – – 28.8/28.6 21.2/20.8
310-forced MD 6.4 13 219 24 9 27.3/26.9 20.7/19.5
*RMSD  ¥(EL)2  (EL)2, where EL and EL denote the deviations between the EL and EL angles for the model structure and the closest
set of the corresponding angles in the experimental restrictions. The summation runs over the three labeled peptide planes.
†Tilt angle between the average molecular axis and the membrane normal (i.e., B0).
‡Rotation around the molecular axis (positive, counterclockwise looking toward the C-terminal), starting from the position where the direction from the
helix axis to C for the first residue follows the positive tilt direction around the center of the molecule.
§Tilt angles for the average molecular axis through the N- (N) and C- (C) terminal residues with the breakpoint at residue 11 (310-forced MD), 12
(wild-type MD), 13 (XRD), and N and C reflect the two structure elements for the - and 310-helix combinations. These angles are not given for largely
straight structures.
¶Distance/height (projection) between the C in Aib1 to Phol20 (2–3 Å shorter than the full peptide including side chains).
Estimated to the distance/height (projection) from N in Pro2 to N in Aib16.
**Structure determined by Fox and Richards (1982).
††Simple models calculated using torsion angles of     57° (-helix) and   50°,   20° (310-helix).
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planes. As exemplified by the wild-type MD structure (Fig.
5 D), some of the models display a minor kink within the
Gly11-X-X-Pro14 motif, which conveniently may be char-
acterized by specification of tilt angles N and C for the
average molecular axes of the N- and C-terminals of the
peptide, respectively, relative to the bilayer normal. Thus,
for this specific structure, the   11° tilt angle represents
an average picture of N- (residues 1 to 12) and C-terminal
(residues 13 to 20) structure elements tilting with as differ-
ent angles as N  20° and C  3° relative to the bilayer
normal. We note that the overall kink of 17° for this
structure is in good agreement with model structures earlier
reported, e.g., by Sansom and coworkers (Breed et al., 1997;
Tieleman et al., 1999b).
Optimized orientation parameters for the various model
structures, including those obtained by XRD (Fox and Rich-
ards, 1982) and molecular dynamics calculations, are sum-
marized in Table 2 with the optimum membrane configu-
ration for several of the models illustrated in Fig. 5. In
addition to the various tilt angles, Table 2 also includes
numbers for the overall length of the peptide backbone and
the hydrophobic core region of the peptide as well as the
height (projection) of these along the bilayer normal when
adopting the optimum tilted conformation. Overall, this
analysis indicates that the optimum configuration for all
models require a tilt of the molecular axis by angles of
8–21° relative to the bilayer normal. Furthermore, among
the nine investigated structures, it appears that the solid-
state NMR data are most compatible with the straight -he-
lix (RMSD  4.2), the wild-type 100-ps MD structure
(RMSD  5.1), and the straight 310 helix (RMSD  5.7),
which all are associated with a somewhat lower RMSD
value than the XRD structure (RMSD  13.6). In the
evaluation of these numbers, however, it is important to
keep in mind that we, for practical reasons, consider only a
limited number of model structures, and the compatibility
check of these takes their origin in structural constraints
from only 3 out of 20 amino acids. This provides, on one
hand, an interesting test on the utility of very few constraints
in structural analysis but, on the other hand, also implies
that it is important to critically evaluate the solutions in
relation to earlier findings and general rules concerning the
relation between primary and secondary structures for
amino acid sequences.
DISCUSSION
Although the tilted 310 structure in Fig. 5 C matches the
experimental restrictions quite well, it is probably not the
most realistic solution for several other reasons. First, this
structure is incompatible with all experimental and molec-
ular simulation data established so far in the sense that none
of these suggest an extended helix in the N-terminal of the
peptide. Second, the hydrophilic Aib3, Gln7, Aib10, Pro14,
and Glu18 residues (C carbons marked by black dots in Fig.
5 C) are not prevailingly located on one side of the peptide
as would be expected for an amphipatic ion-channel pep-
tide. Third, even with a tilt angle   20°, this peptide
would have an overall backbone height (i.e., projection onto
the bilayer normal) of 36 Å along bilayer normal, which is
significantly larger than the hydrophobic (hydrocarbon) re-
gion of the phospholipid bilayer and may thereby force
some of the hydrophobic residues into the polar outer re-
gions of the bilayer. That this indeed may be the case
becomes evident by comparing the thickness of 23–24 Å for
the hydrophobic region of a fully hydrated DMPC bilayer
(Lewis and Engelman, 1983; Scherer, 1989) with an esti-
FIGURE 7 RMSD between the alamethicin solid-state NMR restrictions
and structural constraints from (A) the XRD structure (Fox and Richards,
1982), (B) a straight -helix ( 57°), and (C) the 100-ps wild-type
MD structure as function of the tilt-angle  between the molecular axis and
the bilayer normal and the rotational pitch  around the molecular axis. The
optimimum orientations corresponding to the different structures are visu-
alized in Fig. 5.
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mated height of 26 Å for the hydrophobic region of the
peptide along the bilayer normal. Thus, although the Aib16
and Aib17 very well could be part of the polar C-terminal
anchor outside the lipid hydrocarbon region (Barranger-
Mathys et al., 1994, 1996; Kessel et al., 2000) this unfavor-
able match would either expose one of the hydrophobic
Val15 or Pro2 residues to the polar water–phosphate surface
of the membrane or require considerable deformation of the
bilayer. In this context, it is relevant to note that recent
studies have described a decrease in the bilayer thickness as
an element in hydrophobic matching between ionophores
and phospholipid bilayers (Harroun et al., 2000; Kessel et
al., 2000).
For several reasons, the low-RMSD straight -helix (Fig.
5 B) and wild-type MD (Fig. 5 D) structures represent more
realistic models than does the 310 helix for alamethicin in
DM PC phospholipid bilayers. First, they are largely com-
patible with all available secondary structure information.
Second, due to more compact structures (17–20-Å height of
the hydrophobic region), they offer better conditions for
hydrophobic match to the hydrated DMPC bilayers. Third,
both structures have the hydrophilic Aib3, Gln7, Aib10,
Pro14, and Glu18 residues and their polar side chains located
on the same side of the peptide, regarded as important for
the amphipatic character of the peptide and for the polar
lining in the aqueous lumen of a multimeric alamethicin
pore. Furthermore, in accord with earlier findings (Breed et
al., 1997), the aromatic side chains and the hydroxyl group
of the C-terminal Phol20 are located at the opposite side of
the peptide (i.e., the exterior of a potential helix bundle)
being compatible with models where the C-terminal forms
an anchor to the phosphate groups in the lipid–water sur-
face. Among the two structures, the tilted -helix benefits
from the lowest RMSD value and could represent a reason-
able model for alamethicin inserted into lipid bilayers,
which may have a helix-stabilizing or straightening-out
effect on the proline-induced kink (Schwarz et al., 1986;
North et al., 1995). In particular, the adoption of a more
regular -helical structure in the C-terminal than the more
extended structures deduced by solution NMR (Franklin et
al., 1994) and XRD (Fox and Richards, 1982) would be
possible considering that the conformation of the partly
flexible C-terminal may undergo substantial conformation
changes upon transfer from water/methanol or crystal to
phospholipid bilayer environments. That this indeed may be
the case has recently been investigated by Kessel et al.
(2000) using continuum solvent model calculations of ala-
methicin–membrane interactions and by Tieleman et al.
(1999b,c) using molecular dynamics calculations in solution
and membrane environments. Likewise, the tilt of the helix
by 17° relative to the bilayer normal may be reasonable,
seen in the light that numerous structural studies of mem-
brane proteins recently have reported tilt angles in this order
for transmembrane -helices in membrane proteins (e.g.,
Bowie, 1997).
The 100-ps wild-type MD structure (Fig. 5 D), with the
average molecular axis tilted by 11° relative to be bilayer
normal, also gives quite a good match to the solid-state
NMR restrictions and contains all currently debated ele-
ments in its structure. This includes a reasonably sized kink
within the Gly11-X-X-Pro14 motif, a partly unwound struc-
ture in the C-terminal, and good conditions for polar lining
inside a multimeric pore. For this model, it is interesting to
note that the overall tilt of the molecule is induced by a
substantial tilt of the N-terminal (N  20°) as opposed to a
largely transmembrane-oriented C-terminal (C  3°). This
optimum orientation of the peptide relative to the membrane
differs from the common picture inspired from the early
XRD work of Fox and Richards (1982), where the C-
terminal is believed to tilt away from the pore direction of
a multimeric transmembrane channel. In fact, this picture
also emerged from our optimization of the XRD structure to
the solid-state NMR restrictions as visualized in Fig. 5 A. In
the comparison of the XRD and MD structures, it should be
noticed that they have almost identical overall tilt angles
with respect to the bilayer normal, and that a 180° rotation
of the wild-type MD structure around the average molecular
axis (i.e., change of rotational pitch angle from  to  
180°) leads to a structure that, to a good approximation, has
interchanged tilts for the C- and N-terminal fragments in
close agreement with the common XRD picture. Although,
this orientation is characterized by a considerably higher
RMSD value, it is quite obvious from the RMSD contour
plot in Fig. 5 C that the traces through  angles in the order
of 5–15° are characterized by two “symmetry-related” min-
ima with RMSD values of 5.1 and 12.1 for the ,  values
of 11°, 231° and 6°, 50°, respectively. It is relevant to note
that, even with an XRD-inspired 180° rotation around the
molecular axis, the wild-type MD structure remains in better
agreement with the solid-state NMR data than does the
XRD structure.
The solid-state NMR restrictions and their compatibility
with various model structures may provide interesting new
elements to the extensive discussion of alamethicin, its
membrane-associated conformation, and its potential for
multimerization and channel formation in the nonconduc-
tive state, which may have consequences also for the oper-
ation in the conductive state. From the solid-state NMR
results, it can be concluded unambiguously that, for the
present peptide:lipid ratio and hydration conditions, the vast
majority of the alamethicin molecules are in a transmem-
brane configuration already in its nonconductive state.
Thus, we find no compatibility with the large number of
models where alamethicin in the nonconductive state forms
monomeric or multimeric rods on the membrane surface
(e.g., Baumann and Mueller, 1974; Banerjee et al., 1985;
Biggin et al., 1997) or a bent structure with the C-terminal
part on the membrane surface and the N-terminal extending
into the membrane (e.g., Fox and Richards, 1982; Franklin
et al., 1994). In turn, this implies that it is unlikely that
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straightening-out of a kink about Pro14 or a flip of barrels
from in-plane to transmembrane configuration is a major
step in the activation of the pore upon introduction of a
transmembrane potential. We note that the situation may be
different at low peptide concentration (Tieleman, 1999a).
Obviously, in contrast, our results support the various “bar-
rel-stave” models with alamethicin oriented in a transmem-
brane fashion in both the nonconductive and the conductive
state (e.g., Huang and Wu, 1991; North et al., 1995; Bar-
ranger-Mathys and Cafiso, 1996; Breed et al., 1997; Jayas-
inghe et al., 1998; Tieleman et al., 1999b,c). In particular, it
should be noted that our results in this respect extend the
conclusions arrived at by North et al. (1995) in their solid-
state NMR analysis of the N-terminal part of the peptide to
cover the full peptide.
Our results provide, for the first time, considerable ex-
perimental evidence that the most favorable orientation of
alamethicin in phospholipid bilayers (specifically fully hy-
drated DMPC) is tilted by 10–20° relative to the bilayer
normal, whereas nontilted conformations did not match the
solid-state NMR restrictions. This should be seen in the
light of previous solid-state NMR (North et al., 1995) and
EPR (Barranger-Mathys and Cafiso, 1996; Jayasinghe et al.,
1998) studies from which it was concluded that alamethicin
is oriented parallel to the bilayer normal, but more recent
model calculations appear to support a tilt in the order
observed in this study (Kessel et al., 2000). In this regard, it
should be emphasized that a tilted configuration would by
no means be a surprise, considering the large number of
tilted helix arrangements described for transmembrane he-
lices (Bowie, 1997; Bywater et al., 2001). For example,
tilted transmembrane helices have recently been determined
experimentally for rhodopsin (Unger et al., 1997; Teller et
al., 2001), the M2 channel of influenza A virus (Kovacs and
Cross, 1997; Kukol et al., 1999), the epidermal growth
factor receptor (Jones et al., 1998), the membrane protein
Vpu from HIV-1 (Marassi et al., 1999), and the nicotinic
acetylcholine receptor (Opella et al., 1999). Using numeri-
cal optimization, we found reasonable compatibility be-
tween the solid-state NMR restrictions and a straight -he-
lix tilting by 17° relative to the bilayer normal and a slightly
bent MD structure with an overall tilt angle of 11°. Both
angles are well within the typical regime of tilt angles for
membrane-spanning helices. On the basis of the low number
of NMR constraints, however, it is impossible to unambig-
uously prefer one or the other of these two possible solu-
tions. We find compatibility with both structures and this
cannot exclude the potential for a slightly bent structure in
the membrane as has been proposed earlier (Barranger-
Mathys and Cafiso, 1996). In this context, we note that
recent MD calculations find evidence for a kink or at least
dynamic hinge bending within the Gly11-X-X-Pro14 motif,
which may be important for the peptide to be able to
accommodate relative motion of the two leaflets of the
bilayer (Tieleman et al., 1999b,c). We note that the slightly
kinked wild-type MD structure, in many respects, bears
resemblance to the XRD structure (Fox and Richards,
1982), which, however, displayed a poorer match to our
solid-state NMR restrictions.
There may be several not yet fully resolved reasons why
alamethicin adopts a tilted orientation in the bilayer in the
nonconductive state. First, several alamethicin monomers
may, in the nonconductive state, form a preaggreate where
a tilted conformation is favorable for the multimerization
generally regarded necessary for the ion channel activity in
the conductive state. Second, as an alternative, the mono-
mers may adopt this orientation by themselves facilitating
multimerization upon introduction of a transmembrane po-
tential. Furthermore, if all helices are perpendicular to the
membrane, it means that the helix–helix crossing angles
will be 0° (or 180° if they are aligned counter-parallel). This
is a very unfavorable crossing angle for helices (Bywater et
al., 2001). With a nonperpendicular tilt angle, it is possible
to construct multimeric aggregates with allowed crossing
angles. Third, alamethicin may be monomeric (although it
may be unlikely at the present high peptide:lipid ratio of
1:8), with a tilted conformation being energetically favor-
able because it provides optimum hydrophobic matching
between the hydrophobic region of the peptide and the
hydrocarbon region of the bilayers. The conformation may
also prevent the side chains of both the C- or the N-terminal
amino acids from moving in and out of hydrophobic or
hydrophilic environments upon rotation of the peptide
around the molecular axis (Jones et al., 1998). We note that
our measurements do not allow for direct discrimination
between monomeric and multimeric structures of alamethi-
cin.
Among the three possible reasons for a tilted conforma-
tion of alamethicin in lipid bilayers, the two monomeric
models do not require further discussion with respect to the
solid-state NMR restrictions. In contrast, it appears reason-
able to investigate how the solid-state NMR-compatible
structures would fit into a multimeric model for alamethicin
in the nonconductive state. In this context, we should men-
tion that several models have been presented in the litera-
ture, which describe the conductive alamethicin channel as
a pore lined by a bundle of approximately parallel -helices
(You et al., 1996; He et al., 1996a; Breed et al., 1997;
Tieleman et al., 1999c). In general, these models accept
different numbers of helices in the bundle, explaining the
multiconductance behavior of the active alamethicin chan-
nel. Seen in this perspective, it would be interesting if the
solid-state NMR compatible structures for alamethicin
would allow for formation of, or describe the presence of, a
multimeric bundle with the hydrofilic residues lining the
pore of the channel. That this is indeed possible is demon-
strated in Fig. 8, containing representative 6-mer alamethi-
cin channels formed by symmetric packing of six differently
rotated (around the bilayer normal) variants of the tilted
-helix and tilted/kinked wild-type MD structures from Fig.
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5, B and D, respectively. Although these multimeric pack-
ing motifs have been established without any attempts to
model the interhelical spacing or specific sidechain interac-
tions, it appears intuitively that the helices in a parallel
arrangement for both models (independent of the number of
participating helices) need to be packed as a left-handed
bundle to ensure the hydrophilic lining in the interior of the
channel. Furthermore, it should be noted that the observa-
tion of a single resonance in the solid-state NMR spectra for
each labeled residue requires that all monomers participat-
ing in these putative channels are oriented identically with
respect to the bilayer normal.
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